NEJM Audio Summary - Feb 23, 2012

Excerpted Script

"Colonoscopy versus Fecal Immunochemical Testing in Colorectal-Cancer Screening" by Enrique Quintero from Hospital Universitario de Canarias, Tenerife, Spain.
This trial comparing colorectal-cancer mortality among patients screened with colonoscopy or fecal immunochemical testing (FIT) will be completed in 2021.  This interim report describes rates of participation, diagnostic findings, and occurrence of major complications at completion of the baseline screening. The rate of participation was higher in the FIT group than in the colonoscopy group (34.2% vs. 24.6%). Colorectal cancer was found in 30 subjects (0.1%) in the colonoscopy group and 33 subjects (0.1%) in the FIT group . Advanced adenomas were detected in 1.9% subjects in the colonoscopy group and 0.9% in the FIT group, and nonadvanced adenomas were detected in 4.2% subjects in the colonoscopy group and 0.4% in the FIT group. Subjects in the FIT group were more likely to participate in screening than were those in the colonoscopy group. On the baseline screening examination, the numbers of subjects in whom colorectal cancer was detected were similar in the two study groups, but more adenomas were identified in the colonoscopy group.

colon, colonoscope, colonoscopy, colorectal...字面で見るとなんともない単語が、耳で聞くとアクセントの移動に伴い印象が変わってしまう好例。